Brief: Eiger Receives European Approval For Zokinvy

Eiger Biopharmaceuticals

20/07/2022 13:49

July 20 (Reuters) - Eiger BioPharmaceuticals Inc  EIGR.O :
    * EIGER RECEIVES EUROPEAN APPROVAL FOR ZOKINVY® (LONAFARNIB)
FOR
HUTCHINSON-GILFORD PROGERIA SYNDROME AND PROCESSING-DEFICIENT
PROGEROID LAMINOPATHIES
    * EIGER BIOPHARMACEUTICALS INC - EIGER EXPECTS TO MAKE
ZOKINVY
AVAILABLE FOLLOWING SUCCESSFUL COMPLETION OF REIMBURSEMENT
DISCUSSIONS COUNTRY-BY-COUNTRY
    * EIGER BIOPHARMACEUTICALS INC -  ZOKINVY NOW APPROVED FOR
USE IN
30 EUROPEAN COUNTRIES, FOLLOWING APPROVAL IN U.S IN 2020
    * EIGER - EUROPEAN COMMISSION'S CENTRALIZED MARKETING
AUTHORIZATION IS VALID IN ALL 27 EU MEMBER STATES AS WELL AS
ICELAND, LIECHTENSTEIN,  NORWAY

Source text for Eikon:  ID:nPnLxgdya 
Further company coverage:  EIGR.O 

 ((Reuters.Briefs@thomsonreuters.com;))